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Background: Anterior mediastinal masses are a rare but well documented finding in Graves disease. The vast
majority of these lesions represents benign thymic hypertrophy and regress after treatment of the hyperthyroidism.
A small percentage of these cases however represent neoplastic/malignant diseases which require further
treatment.
Cases: 12 year old boy with one year history of refractory Graves disease was found to have an anterior mediastinal
mass and underwent curative thyroidectomy for sustained hyperthyroidism. Cervical lymphadenopathy was
detected during the procedure and biopsy was obtained. A 23 year old woman who presented with a one month
history of hyperthyroid symptoms, was diagnosed with Graves disease and also was found to have an anterior
mediastinal mass on imaging. Biopsy of the anterior mediastinal mass was obtained and subsequently the patient
underwent robotic thymectomy. Histologic examination and immunophenotyping of the cervical lymph node in a
12 year old boy revealed neoplastic proliferation of T lymphoblasts diagnostic of T lymphoblastic leukemia/
lymphoma. Examination of the anterior mediastinal mass biopsy in the 23 year old woman revealed type B1
thymoma which was confirmed after examination of the subsequent robotic thymectomy specimen.
Conclusion: This is the first reported case of T cell lymphoblastic lymphoma and the third reported case of
thymoma associated with sustained hyperthyroidism due to Graves disease. These cases indicate that an anterior
mediastinal mass in a patient with active Graves disease may be due to a neoplastic cause, which may require
definitive treatment. Caution should be exercised when dismissing a mediastinal mass as benign thymic hyperplasia
in patients with active Graves disease.
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Graves disease (GD) is an autoimmune disease caused
by self-reactive plasma cells which produce antibodies to
the thyrotropin receptor that stimulate thyroid-
stimulating hormone receptors and increase the produc-
tion of thyroid hormone [1]. The relationship between
Graves disease (GD) and mediastinal masses is nearly a
century old having been first identified in a patient with
thymic hyperplasia secondary to GD described by* Correspondence: ridas.juskevicius@vidanthealth.com
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distribution, and reproduction in any mediumHalsted in 1914 [2]. With a well known benign cause of
anterior mediastinal masses (AMM) in Graves disease,
there is a tendency to forego tissue biopsy and re-
evaluate at an unspecified time after thyroid ablation/
thyroidectomy [2-5]. Here we describe two patients with
neoplastic anterior mediastinal masses associated with
GD, illustrating that this may not be safe approach to all
patients with anterior mediastinal masses and GD.
Case presentations
Patients
A 12 year-old African American male with a one year his-
tory of GD refractory to medical management presented
with a persistent tachycardia, fever, abdominal pain,
vomiting, weakness and muscle aches after discontinuingCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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12× 6 cm mediastinal mass had been identified radio-
graphically which was initially thought to represent thymic
hyperplasia (Figure 1A). Bilateral cervical lymphadenop-
athy was also detected. The decision was made to perform
a curative thyroidectomy. During the procedure a cervical
lymph node biopsy was performed, which demonstrated
architectural effacment by a diffuse infiltrate of immature
lymphoid cells (Figure 1B). The immunophenotyping
by flow cytometry revealed a predominance of T lym-
phoblasts (CD1a+, CD2+, CD4+, CD8+, sCD3-, TdT+)
consistent with T-lymphoblastic leukemia/lymphoma
(T-LBL/L). Bone marrow examination identified involve-
ment by T-LBL. The thyroidectomy specimen contained
changes typical of GD. The patient was treated with in-
duction chemotherapy for T-LBL with excellent response
showing essentially complete resolution of the mediastinal
mass, neck lymph nodes and no bone marrow involve-
ment. Patient has continued to do well post thyroidect-
omy on levothyroxine.
The second patient is a 23-year old female without sig-
nificant medical history who was transferred to our insti-
tution with increasing shortness of breath, dysphagia,
cervical lymphadenopathy and a mediastinal mass iden-
tified on chest CT (Figure 1C). A TSH level was below
the minimum detection limit of 0.02 uIU/m as well as a
free T3 of 12.2 pg/mL (reference range: 3.4-4.8). Biopsies
of the anterior mediastinal mass were obtained and
showed a type B1 thymoma. Cervical lymph node biopsy
revealed dermatopathic lymphadenitis. The patient
underwent a robotic thymectomy and a diagnosis of type
B1 thymoma was confirmed (Figure 1D). Patient had an
uneventful post operative course and was discharged on
post operative day 3.Figure 1 (A and C) Chest computed tomography images showing ant
Type B1 thymoma. (B and D) Representative tissue sections from the samDiscussion
Evaluating an AMM in the setting of GD can be challen-
ging for the clinician. There is no systematic, formal
evaluation of how best to manage AMM in the setting
of GD [3]. There is substantial variability in the rate of
thymic involution as well as thymic size, shape and
density even between individuals of the same age [6]. A
retrospective study of 109 patients with AMM treated
with thymectomy found that all cases with malignancy
had either symptoms referable to the thymus or a
discrete mass rather than a diffusely enlarged thymus
gland [6]. The utility of this information is partially lim-
ited by the finding that a “discrete mass” was seen in
32% of thymic hyperplasias and 66% of histologically
normal thymus glands [6]. Also, symptoms anatomically
referable to enlargement of the thymus (chest discom-
fort, chest pain and shortness of breath) [6] can fre-
quently also be seen in GD [7]. Prevailing wisdom from
several recent case reports of thymic hyperplasia in GD
is that caution should be used in evaluating AMM in the
setting of GD given the known association with thymic
hyperplasia [2-5]. Clinicians are urged to wait until after
resolution of hyperthyroidism to follow up AMM in the
absence of features concerning for malignancy (invasion,
calcifications, cysts or septations) on imaging [2-5]. Re-
duction of thymic enlargement after achieving a
euthryoid state can vary from 2 months up to 2 years [2]
which could complicate following up a possibly neoplas-
tic mediastinal mass.
These cases represent two examples of mediastinal
neoplasms seen in association with GD. While the first
patient represents the first documented case of T-LBL/L
seen in association with GD, there are two prior case
reports of thymoma occuring with GD [8,9]. On theerior mediastinal masses from patients with T-cell LBL/L and
e patients (Hematoxylin-Eosin, x200).
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immune diseases is well documented [10-17].
Autoimmunity alters the environment of the immune
system with positive selection/expansion of autoreactive
T-cells in the thymus. Thymic hyperplasia is a represen-
tation of how GD, in particular, alters the microenviron-
ment of the thymus. This is thought to be due to the
hyperthyroidism associated with active GD. It is known
that thyroid hormones (TH) are able to induce thymic
epithelial cell (TEC) proliferation which produces cyto-
kines (including IL-1) [18]. T3 also enhances thymic
hormone thymulin secretion by TECs [18]. In turn, cyto-
kines (e.g. IL-1) and thymulin stimulate and enhance
thymocyte (immature T-cell precursor) proliferation.
Thymocyte differentiation occurs as the cells migrate
within thymic lobules interacting with microenviron-
ment [18]. In active GD, thymic microenvironment may
be altered due to increased proliferation of TECs driven
by TH. It is unclear if thymic environment altered by
the state of sustained hyperthyroidism, including
increased proliferative drive on maturing thymocytes
and, possibly, abnormal differentiation, may contribute
to the development of genetic lesions resulting in T
LBL/L in susceptible individuals. Likewise it is not un-
reasonable to postulate that TH driven TEC prolifera-
tion may contribute to the pathogenesis of thymoma,
which is a neoplasm of thymic epithelial cells. The two
patients illustrated not only raise the possibility of asso-
ciation between GD and mediastinal neoplasms but rep-
resent a possible reason for caution in using a watch-
and-wait approach to anterior mediastinal masses in
patients with GD.
Conclusions
This is the first reported case of T lymphoblastic lymph-
oma/leukemia and the third reported case of thymoma
developing in patients with sustained poorly controlled
hyperthyroidism due to Graves disease. Given the known
physiologic interactions between thyroid hormones and
thymic microenvironment, these cases may indicate a
possible link between a sustained hyperthyroidism and
the development of thymic neoplasia. In addition, our
cases indicate that an anterior mediastinal mass in a pa-
tient with active Graves disease may be due to a neoplas-
tic cause, which may require definitive treatment.
Caution should be exercised when dismissing a medias-
tinal mass as benign thymic hyperplasia in patients with
active Graves disease.
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